强心剂市场(主要地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00029971
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Cardiotonic Agents Market Developments by 2031

Buy Now

市场分析
强心剂是用于改善心肌收缩力的药物,有助于有效的血液循环。心功能不全会导致器官供血不足,从而导致疲倦、呼吸困难和水肿。缺血性心脏病和动脉高血压是心功能不全的两个主要原因,用于治疗的药物称为强心剂。还有其他几种药物,如苷类、拟交感神经药等,可用于治疗充血性心力衰竭、心脏外科手术、休克和其他病症。

增长驱动因素和挑战
新的和改进的强心药不断被开发并在全球市场上推出。一些创新药物正在被开发出来,以专注于特定的心力衰竭机制。通过开发副作用减少的新药可以提高现有药物的有效性。世界卫生组织(WHO)估计,每五名因心血管疾病死亡的人中,就有四人是由心脏病和中风等心血管疾病引起的。

随着个性化医疗技术的发展,强心剂市场有望迎来新的增长前景例如基因检测变得更加普遍。医疗保健专业人员倾向于通过定位与心力衰竭相关的特定遗传标记来为患者提供个性化治疗,或许可以改善治疗结果。此外,人口老龄化、高血压、心肌梗塞和心力衰竭等各种因素预计将支持强心剂市场的增长。据美国心脏协会称,到 2030 年,预计将有超过 650 万北美人患有心力衰竭,使总数超过 800 万。此外,美国心脏协会还表示,由于患者数量不断增加,北美心力衰竭的总体护理费用预计将从2012年的307亿美元增加到2030年的697亿美元。

报告分段和范围
“到 2030 年全球强心剂市场分析”是一项专门深入的研究,重点关注全球强心剂市场趋势和增长机会。该报告旨在概述全球强心剂市场,并按药物类型、测试类型、应用、剂型、给药途径、分销渠道和地理位置进行详细的市场细分。全球强心剂市场近年来经历了高速增长,预计在预测期内将继续这种趋势。该报告提供了全球强心剂使用情况及其主要地区和国家需求的关键统计数据。此外,该报告还对影响主要地区和国家强心剂市场表现的各种因素进行了定性评估。该报告还对领先的强心剂市场参与者及其关键战略发展进行了全面分析。还包括对市场动态的一些分析,以帮助确定关键驱动因素、市场趋势和有利可图的强心剂市场机会,从而有助于确定主要收入来源。

此外,生态系统分析和波特五力分析提供了全球强心剂市场的 360 度视角。这有助于了解整个供应链和各种市场增长因素。

< strong>细分分析
全球强心剂市场规模基于细分药物类型、用途、给药途径、剂型、分销渠道和地理。强心剂市场根据药物类型细分为洋地黄糖苷、磷酸二酯酶抑制剂、心脏保护剂、拟交感神经药等。磷酸二酯酶抑制剂的使用增加预计将增加强心剂的市场。根据应用,市场分为心脏外科手术、心房颤动、心力衰竭、肺动脉高压等。心脏外科手术在 2022 年占据最大的市场份额,并且由于需求增加,预计在预测期内将稳步扩大用于心脏手术,如瓣膜置换术、搭桥手术和心脏移植。

此外,给药途径分为口服和胃肠外给药。根据剂型,市场分为片剂、溶液剂等。根据分销渠道,强心剂市场分为医院药房、零售药房和网上药房。

Cardiotonic Agents market Market: Strategic Insights

Cardiotonic Agents market Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Amneal Pharmaceuticals LLC
  • Pfizer Inc
  • Hikma Pharmaceuticals PLC
  • Fresenius Kabi
  • Midas Pharma GmbH
  • Sanofi
  • Aurobindo Pharma Limited
  • SimSon Pharma Limited

Regional Overview

Regional And Country Scope
  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
  • 中东和非洲

Market Segmentation

Segment 1药物类型
  • 洋地黄苷
  • 磷酸二酯酶抑制剂
  • 心脏保护剂
  • 拟交感神经药等
Segment2应用
  • 心脏外科手术
  • 心房颤动
  • 心力衰竭
  • 肺动脉高压等
Segment3给药途径
  • 口服和肠外
Segment4剂型
  • 片剂
  • 溶液和其他

区域分析
由于心血管疾病的高患病率、医疗保健支出的增加和先进的医疗保健,北美强心剂市场预计将主导全球市场基础设施。美国在北美强心剂市场中占有最大的市场份额,因为诺华、默克等大多数主要参与者都在美国。 Co.、安进 (Amgen)、辉瑞 (Pfizer) 等公司都在美国开展业务。这些公司积极参与强心药物的产品开发、创新和营销。例如,2022 年 1 月,默克公司 (Merck & Co., Inc.宣布Vericiguat完成II期临床试验,该药物通过激活鸟苷酸环化酶改善心脏功能。

此外,由于老年人群中心血管疾病的患病率不断上升,亚太地区预计全球强心剂市场的复合年增长率最高。由于人们对强心剂潜在益处的认识显着提高,强心剂的市场扩张受到医学界的显着影响。此外,可支配收入的增加和心血管疾病的日益流行可能会增加亚太地区对这些药物的需求。

行业发展和未来机遇
合作、收购、产品批准、产品开发和新产品发布是全球强心剂市场参与者采取的主要策略。

  • 2022年2月,罗氏完成了呋塞米药物的III期临床试验。该药用于治疗心力衰竭;它是一种袢利尿剂,可减少体内液体积聚并改善心脏功能。
  • 2021年11月,诺华完成了其口服凝血酶抑制剂药物Entresto的III期临床试验。该药物用于射血分数保留的心力衰竭情况。这是心力衰竭的一种主要形式,治疗起来很困难。
  • 2021年12月,辉瑞公司完成了其口服凝血酶抑制剂Betrixaben药物的III期临床试验。 Betrixaben 用于预防急症患者的血栓。

< strong>新冠疫情的影响/地缘政治形势的影响/经济衰退的影响
covid-19大流行导致全球许多行业的进步下降。全球制造工厂的关闭和贸易限制导致全球制造商的供应链受到限制。由于药物供应有限和全球心脏手术数量减少,强心剂市场增长在大流行期间突然下降。这是因为世界各地取消了许多非必要的外科手术。相反,在市场利益相关者和医疗保健从业者为管理中断的供应链做出巨大努力之后,强心剂市场正在增长。由于心力衰竭发病率的增加以及易患心血管疾病的老年人口的增加,对强心剂的需求不断增长,推动了市场的增长。 2021 年,COVID-19 疫苗的推出取得了积极成果,导致产量增加,以满足大量人口不断增长的需求。此外,从 COVID-19 中康复的患者正在经历心血管问题,这可能会在不久的将来加剧对强心剂的需求。

市场参与者

竞争格局和主要公司
< span style="font-size: 10pt; font-family: verdana, Geneva, sans-serif;">强心剂市场的一些主要参与者包括 Amneal Pharmaceuticals LLC、Midas Pharma GmbH、诺华 (Novartis)、辉瑞 (Pfizer Inc.)、默克公司Co., Inc.、Hikma Pharmaceuticals PLC、Fresenius Kabi、Midas Pharma GmbH、赛诺菲、Aurobindo Pharma Limited 和 SimSon Pharma Limited 等

Cardiotonic Agents market Market Report Scope

Report Attribute Details
Market size in US$ XX million
Market Size by US$ XX Million
Global CAGR XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 药物类型
  • 洋地黄苷
  • 磷酸二酯酶抑制剂
  • 心脏保护剂
  • 拟交感神经药等
By 应用
  • 心脏外科手术
  • 心房颤动
  • 心力衰竭
  • 肺动脉高压等
By 给药途径
  • 口服和肠外
By 剂型
  • 片剂
  • 溶液和其他
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太地区其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Amneal Pharmaceuticals LLC
  • Pfizer Inc
  • Hikma Pharmaceuticals PLC
  • Fresenius Kabi
  • Midas Pharma GmbH
  • Sanofi
  • Aurobindo Pharma Limited
  • SimSon Pharma Limited
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Amneal Pharmaceuticals LLC
    2. Pfizer Inc.
    3. Hikma Pharmaceuticals PLC
    4. Fresenius Kabi
    5. Midas Pharma GmbH
    6. Sanofi
    7. Aurobindo Pharma Limited
    8. SimSon Pharma Limited.
    9. Novartis
    10. Merck & Co. Inc.

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Pharmaceuticals : READ MORE..